Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Humanization of the entire murine Mapt gene provides a murine model of pathological human tau propagation
Takashi Saito, Naomi Mihira, Yukio Matsuba, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 34, pp. 12754-12765
Open Access | Times Cited: 183

Showing 1-25 of 183 citing articles:

Synergy between amyloid-β and tau in Alzheimer’s disease
Marc Aurel Busche, Bradley T. Hyman
Nature Neuroscience (2020) Vol. 23, Iss. 10, pp. 1183-1193
Closed Access | Times Cited: 881
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Yun Zhang, Huaqiu Chen, Ran Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 396
From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy
Morvane Colin, Simon Dujardin, Susanna Schraen‐Maschke, et al.
Acta Neuropathologica (2019) Vol. 139, Iss. 1, pp. 3-25
Open Access | Times Cited: 158
Mouse Models of Alzheimer’s Disease
Miyabishara Yokoyama, Honoka Kobayashi, Lisa Tatsumi, et al.
Frontiers in Molecular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 136
Recent Advances in the Modeling of Alzheimer’s Disease
Hiroki Sasaguri, Shoko Hashimoto, Naoto Watamura, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 116
Transgenic Mouse Models of Alzheimer’s Disease: An Integrative Analysis
Raquel Sánchez‐Varo, Marina Mejias‐Ortega, Juan José Fernandez-Valenzuela, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5404-5404
Open Access | Times Cited: 84
Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q
Joshua Spurrier, LaShae Nicholson, Xiaotian T. Fang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 647
Open Access | Times Cited: 71
Updates on mouse models of Alzheimer’s disease
Michael Z Zhong, Thomas Peng, Mariana Lemos Duarte, et al.
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 51
The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromes
Sarah Buchholz, Hans Zempel
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3606-3628
Open Access | Times Cited: 24
Anything but small: Microarousals stand at the crossroad between noradrenaline signaling and key sleep functions
Anita Lüthi, Maiken Nedergaard
Neuron (2025)
Open Access | Times Cited: 5
Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved
Eftychia Vasili, Antonio Dominguez‐Meijide, Tiago F. Outeiro
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 95
An App knock-in rat model for Alzheimer’s disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments
Keliang Pang, Richeng Jiang, Wei Zhang, et al.
Cell Research (2021) Vol. 32, Iss. 2, pp. 157-175
Open Access | Times Cited: 87
Metformin attenuates plaque-associated tau pathology and reduces amyloid-β burden in APP/PS1 mice
Yanxing Chen, Shuai Zhao, Ziqi Fan, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43
Airi Tarutani, Tadashi Adachi, Hiroyasu Akatsu, et al.
Acta Neuropathologica (2022) Vol. 143, Iss. 6, pp. 613-640
Open Access | Times Cited: 47
Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer’s disease pathologies
Sunwoo Chung, June‐Hyun Jeong, Jong‐Chan Park, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 9, pp. 1936-1951
Open Access | Times Cited: 11
Insights on the Use of Transgenic Mice Models in Alzheimer’s Disease Research
Mafalda Soares Pádua, José Luis Guil‐Guerrero, José A. M. Prates, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2805-2805
Open Access | Times Cited: 10
Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2
Jong‐Chan Park, Jong Won Han, Woochan Lee, et al.
Advanced Science (2024)
Open Access | Times Cited: 9
Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
Cutler T. Lewandowski, Juan Maldonado Weng, Mary Jo LaDu
Neurobiology of Disease (2020) Vol. 139, pp. 104811-104811
Open Access | Times Cited: 61
Synergistic toxicity between tau and amyloid drives neuronal dysfunction and neurodegeneration in transgenic C. elegans
Sarah J. Benbow, Timothy J. Strovas, Martin Darvas, et al.
Human Molecular Genetics (2019) Vol. 29, Iss. 3, pp. 495-505
Open Access | Times Cited: 59
Alzheimer’s disease-related dysregulation of mRNA translation causes key pathological features with ageing
Anshua Ghosh, Keiko Mizuno, Sachin S. Tiwari, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 59
The Positive Side of the Alzheimer’s Disease Amyloid Cross-Interactions: The Case of the Aβ 1-42 Peptide with Tau, TTR, CysC, and ApoA1
Lidia Ciccone, Chenghui Shi, Davide Di Lorenzo, et al.
Molecules (2020) Vol. 25, Iss. 10, pp. 2439-2439
Open Access | Times Cited: 57
α-synuclein strains that cause distinct pathologies differentially inhibit proteasome
Genjiro Suzuki, Sei Imura, Masato Hosokawa, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 55
Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia
Diana P. Benítez, Shenyi Jiang, Jack Wood, et al.
Molecular Neurodegeneration (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 51
Remembering your A, B, C's: Alzheimer's disease and ABCA1
Cutler T. Lewandowski, Megan S. Laham, Gregory R. J. Thatcher
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 3, pp. 995-1018
Open Access | Times Cited: 34
Non-invasive imaging of tau-targeted probe uptake by whole brain multi-spectral optoacoustic tomography
Patrick Vagenknecht, Artur Luzgin, Maiko Ono, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 7, pp. 2137-2152
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top